Fort Myers, Fla., August 5, 2019 — Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the appointment of Nathan H. Walcker to the Executive Leadership Team as Chief Financial Officer. In this role, Walcker will oversee the organization’s finance and accounting operations, business planning and investments, and fiscal compliance policy and practices.
He brings over a decade of diverse healthcare industry experience and finance expertise to FCS, most recently serving as an integral member of Bank of America Merrill Lynch’s healthcare investment banking group, where he was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies.
Walcker earned an MBA from Columbia Business School and a bachelor’s degree in Economics from Columbia University.
Deeply committed to community service, Walcker serves on several community boards. He previously served as a board member of Lime Connect, a nonprofit that connects high potential students and professionals with disabilities with professional development opportunities.
“We are impressed with Nathan’s energy and his passion for delivering on our mission,” said FCS CEO Brad Prechtl, MBA. “He is well-equipped to provide the level of strategic financial guidance and leadership that will enhance our capacity and effectiveness in serving patients who are battling cancer.”
FCS President & Managing Physician Dr. Lucio N. Gordan added, “Nathan’s strong financial background and business acumen, as well as his particular focus on best practices and technology, will enable us to continuously improve both the cost and quality of patient care."